secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001609550-26-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical posts preliminary Q4 rev ~$269M (+12% YoY); 2026 guidance $1,003-1,013M
--------------------------------------------------------------------------------

- Preliminary Q4 2025 revenue ~$269M, up 12% YoY; full-year 2025 revenue ~$912M, up 14% YoY.
- Initial FY 2026 revenue guidance of $1,003M-$1,013M, implying 10-11% growth over 2025.
- Appointed Matt Osberg as EVP and CFO, start Jan 19, 2026; base salary $650k, sign-on $600k, equity awards $3M.
- Rick Buchholz steps down as CFO, serves as interim CFO through filing of 2025 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000006/0001609550-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000006/insp-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001609550-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer